PURPOSE: Unplanned conversion is sometimes necessary during minimally invasive liver resection (MILR) of hepatocellular carcinoma (HCC). The aims of this study were to compare surgical outcomes of planned MILR and unplanned conversion and to investigate the risk factors after unplanned conversion. METHODS: We retrospectively analyzed 286 patients who underwent MILR with HCC from January 2006 to December 2017. All patients were divided into a MILR group and an unplanned conversion group. The clinicopathologic characteristics and outcomes were compared between the 2 groups. In addition, surgical outcomes in the conversion group were compared with the planned open surgery group (n = 505). Risk factors for unplanned conversion were analyzed. RESULTS: Of the 286 patients who underwent MILR, 18 patients (6.7%) had unplanned conversion during surgery. The unplanned conversion group showed statistically more blood loss, higher transfusion rate and postoperative complication rate, and longer hospital stay compared to the MILR group, whereas no such difference was observed in comparison with the planned open surgery group. There were no significant differences in overall and disease-free survival among 3 groups. The right-sided sectionectomy (right anterior and posterior sectionectomy), central bisectionectomy and tumor size were risk factors of unplanned conversion. CONCLUSION: Unplanned conversion during MILR for HCC was associated with poor perioperative outcomes, but it did not affect long-term oncologic outcomes in our study. In addition, when planning right-sided sectionectomy or central bisectionectomy for a large tumor (more than 5 cm), we should recommend open surgery or MILR with an informed consent for unplanned open conversions.
PURPOSE: Unplanned conversion is sometimes necessary during minimally invasive liver resection (MILR) of hepatocellular carcinoma (HCC). The aims of this study were to compare surgical outcomes of planned MILR and unplanned conversion and to investigate the risk factors after unplanned conversion. METHODS: We retrospectively analyzed 286 patients who underwent MILR with HCC from January 2006 to December 2017. All patients were divided into a MILR group and an unplanned conversion group. The clinicopathologic characteristics and outcomes were compared between the 2 groups. In addition, surgical outcomes in the conversion group were compared with the planned open surgery group (n = 505). Risk factors for unplanned conversion were analyzed. RESULTS: Of the 286 patients who underwent MILR, 18 patients (6.7%) had unplanned conversion during surgery. The unplanned conversion group showed statistically more blood loss, higher transfusion rate and postoperative complication rate, and longer hospital stay compared to the MILR group, whereas no such difference was observed in comparison with the planned open surgery group. There were no significant differences in overall and disease-free survival among 3 groups. The right-sided sectionectomy (right anterior and posterior sectionectomy), central bisectionectomy and tumor size were risk factors of unplanned conversion. CONCLUSION: Unplanned conversion during MILR for HCC was associated with poor perioperative outcomes, but it did not affect long-term oncologic outcomes in our study. In addition, when planning right-sided sectionectomy or central bisectionectomy for a large tumor (more than 5 cm), we should recommend open surgery or MILR with an informed consent for unplanned open conversions.
Authors: Gi Hong Choi; Sung Hoon Choi; Sung Hoon Kim; Ho Kyoung Hwang; Chang Moo Kang; Jin Sub Choi; Woo Jung Lee Journal: Surg Endosc Date: 2012-02-04 Impact factor: 4.584
Authors: Jack P Silva; Nicholas G Berger; Ziyan Yin; Ying Liu; Susan Tsai; Kathleen K Christians; Callisia N Clarke; Harveshp Mogal; T Clark Gamblin Journal: HPB (Oxford) Date: 2017-11-26 Impact factor: 3.647
Authors: F Cauchy; D Fuks; T Nomi; L Schwarz; L Barbier; S Dokmak; O Scatton; J Belghiti; O Soubrane; B Gayet Journal: Br J Surg Date: 2015-04-02 Impact factor: 6.939
Authors: Mark C Halls; Federica Cipriani; Giammauro Berardi; Leonid Barkhatov; Panagiotis Lainas; Mohammed Alzoubi; Mathieu D'Hondt; Fernando Rotellar; Ibrahim Dagher; Luca Aldrighetti; Roberto I Troisi; Bjorn Edwin; Mohammed Abu Hilal Journal: Ann Surg Date: 2018-12 Impact factor: 12.969
Authors: Zachary E Stiles; Evan S Glazer; Jeremiah L Deneve; David Shibata; Stephen W Behrman; Paxton V Dickson Journal: Ann Surg Oncol Date: 2018-11-19 Impact factor: 5.344
Authors: Andreas Andreou; Benjamin Struecker; Nathanael Raschzok; Felix Krenzien; Philipp Haber; Simon Wabitsch; Christoph Waldbaur; Eva-Maria Touet; Anne-Christine Eichelberg; Georgi Atanasov; Matthias Biebl; Marcus Bahra; Robert Öllinger; Moritz Schmelzle; Johann Pratschke Journal: Surg Oncol Date: 2018-10-09 Impact factor: 3.279
Authors: Dai Hoon Han; Sung Hoon Choi; Eun Jung Park; Dae Ryong Kang; Gi Hong Choi; Jin Sub Choi Journal: Int J Med Robot Date: 2015-11-04 Impact factor: 2.547
Authors: Hyojin Shin; Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; Hae Won Lee; Jun Suh Lee; Boram Lee; Moonhwan Kim; Yeongsoo Jo Journal: J Minim Invasive Surg Date: 2021-12-15